Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neurology Care, Diagnostics, and Emerging Therapies of the Patient With Duchenne Muscular Dystrophy

1 Oct 2018

Abstract excerpt

gene disrupts dystrophin (protein) production, causing damage to muscle integrity, weakness, loss of ambulation, and cardiopulmonary compromise by the second decade of life. Life expectancy has improved from mid-teenage years to mid-20s with the use of glucocorticoids and beyond the third decade with ventilator support and multidisciplinary care. However, Duchenne muscular dystrophy is associated with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mitochondrial Function and Pathology
Share to Muscle Physiology and Disorders
Share to Neurogenetic and Muscular Disorders Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30275245
DOI: 10.1542/peds.2018-0333c

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neurology Care, Diagnostics, and Emerging Therapies of the Patient With Duchenne Muscular DystrophyPMID 30275245Read ↗

Advances in the Treatment of Duchenne Muscular Dystrophy: New and Emerging PharmacotherapiesSemantic proximity Read ↗

Advances in the pharmacotherapeutic management of duchenne muscular dystrophy: an update.Semantic proximity Read ↗

Duchenne Muscular Dystrophy: Integrating Current Clinical Practice with Future Therapeutic and Diagnostic HorizonsSemantic proximity Read ↗

An Overview of Recent Therapeutics Advances for Duchenne Muscular Dystrophy.Semantic proximity Read ↗

Molecular and Biochemical Therapeutic Strategies for Duchenne Muscular DystrophySemantic proximity Read ↗

Current and Emerging Therapeutic Strategies for the Treatment of Duchenne Muscular Dystrophy.Semantic proximity Read ↗

Emerging therapies for Duchenne muscular dystrophy.Semantic proximity Read ↗

Therapeutic approaches for Duchenne muscular dystrophy.Semantic proximity Read ↗

Emerging drugs for Duchenne muscular dystrophySemantic proximity Read ↗

Gene therapy for Duchenne muscular dystrophy: an update on the latest clinical developments.Semantic proximity Read ↗

The DMD gene and therapeutic approaches to restore dystrophin.Semantic proximity Read ↗

Comprehensive analysis of 2097 Patients with Dystrophinopathy Based on a Database From 2011 to 2021Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.